| Literature DB >> 29844800 |
Tong Li1,2, Wenqian Zhang1, Qing Xu3, Shentao Li4, Xuehong Tong3, Jie Ding5, Hui Li1, Shengcai Hou1, Zhidong Xu2, David M Jablons2, Liang You2.
Abstract
Donor organ rejection remains a significant problem. The present study aimed to assess whether transferring a donor's major histocompatibility complex (MHC) genes to the recipient could mitigate rejection in organ transplantation. Seven loci of MHC genes from donor mice were amplified and ligated into vectors; the vectors either contained one K locus, seven loci or were empty (control). The vectors were subsequently injected into the thymus of recipients (in heterotransplants, recipient rats received the vector containing one K locus), following which donor mouse hearts were transplanted. Following the transplantation of allograft and heterograft, electrocardiosignals were viable for a significantly longer duration in recipient mice and rats receiving the donor histocompatibility-2 complex (H-2)d genes compared with those in controls, and in mice that received seven vectors compared with those receiving one vector. Mixed lymphocyte cultures containing cells from these recipients proliferated significantly less compared with mixed lymphocyte cultures containing controls. Also, hearts from H-2d genes-treated recipients demonstrated less lymphocyte infiltration and necrosis compared with the control recipient. The present study concluded that allograft and heterograft rejection may be mitigated by introducing the donor's MHC into the recipient; transferring seven loci has been demonstrated to be more effective than transferring one locus.Entities:
Keywords: major histocompatibility complex; thymus; transplantation
Year: 2018 PMID: 29844800 PMCID: PMC5958787 DOI: 10.3892/etm.2018.6058
Source DB: PubMed Journal: Exp Ther Med ISSN: 1792-0981 Impact factor: 2.447